Date Title Description PDF
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download
03 Nov 2021 On buy-back programmes The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. Download
16 Jul 2021 On Corporate Governance ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company   Download

Pages

Date Title Description PDF
26 Feb 2020 Annual Corporate Governance Report ROVI releases the 2019 Annual Corporate Governance Report Download
26 Feb 2020 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors  Download

Pages

Date Title Description PDF
25 Jul 2017 Otros sobre Gobierno Corporativo The Company informes about the modification of the Internal code of conduct Download
10 Jul 2017 Contratos de liquidez y contrapartida (2) The Company informs that has signed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Download
10 Jul 2017 Contratos de liquidez y contrapartida (1) The Company informs that has cancelled the liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Download
04 Jul 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2017 Download
23 Jun 2017 Información sobre dividendos The Company informes about the dividends payment Download

Pages